Someone at the Yahoo board said it was 74% for and 26% against and there would be a company update in January. Don't know how credible the poster is, but someone seems to have liked the decision based on the stock price today, or feels that some positives to the SP will accrue from all this. I wish shareholders had a better grasp as to what direction the company is going. The CEO letter was helpful, and laid out a pretty good case of voting against it, which I did. The company needs to now articulate how whatever action they take will benefit shareholders, and what their strategy is for the company and maximizing SH value. They have a nice little company here with several positives going for it (existing revenues are growing, Zydax for animals and possibly humans, state of the art manufacturing facility that started production in '17 and that the company previously stated was worth about $50 million, or $2.70 or so per share). I have been holding over a year, and hopefully 2018 will be the year in which shareholders are rewarded somehow.
News 
Market Data 
Discover 
